Stent thrombosis associated with newer P2Y12 inhibitors (ticagrelor & pasugrel) in a STEMI patient
| Autor: | Ahmed Mousa, Ibrahim Mahmoud Elkhouly, Rajesh Rajan, Peter A Brady, Raja Dashti, Vladimir Kotevski, Nader Alasousi, Mohammed Al Jarallah |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Percutaneous business.industry 030204 cardiovascular system & hematology Clopidogrel medicine.disease 030226 pharmacology & pharmacy Thrombosis Stemi patient 03 medical and health sciences 0302 clinical medicine medicine.anatomical_structure P2Y12 Internal medicine medicine Cardiology cardiovascular diseases Stent thrombosis business Ticagrelor Artery medicine.drug |
| Zdroj: | IHJ Cardiovascular Case Reports (CVCR). 3:26-30 |
| ISSN: | 2468-600X |
| DOI: | 10.1016/j.ihjccr.2019.04.002 |
| Popis: | A 54-year-old Kuwaiti male presented an inferior wall ST elevation myocardial infarction (STEMI). Clopidogrel 600mg was administered by the first medical contact and Ticagrelor 180 mg with intravenous (IV) glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitor infusion for 24 hours after primary percutaneous intervention. Despite this, several episodes of stent thrombosis occurred during the subsequent days. Because of this, Ticagrelor was switched to Pasugrel and the patient was loaded with 60mg of Pasugrel. Unfortunately, further in-stent thrombosis occurred and therefore, after discussion, coronary artery bypass graft surgery was performed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|